| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |